KB Financial Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $36K | Buy |
205
+31
| +18% | +$5.44K | 0.01% | 291 |
|
|
2023
Q2 | $33K | Hold |
174
| – | – | 0.01% | 310 |
|
|
2023
Q1 | $35K | Hold |
174
| – | – | 0.01% | 297 |
|
|
2022
Q4 | $41K | Hold |
174
| – | – | 0.01% | 279 |
|
|
2022
Q3 | $35K | Hold |
174
| – | – | 0.01% | 276 |
|
|
2022
Q2 | $25K | Sell |
174
-13
| -7% | -$1.87K | 0.01% | 312 |
|
|
2022
Q1 | $31K | Sell |
187
-11
| -6% | -$1.82K | 0.01% | 313 |
|
|
2021
Q4 | $34K | Sell |
198
-1,057
| -84% | -$182K | 0.01% | 324 |
|
|
2021
Q3 | $237K | Buy |
1,255
+205
| +20% | +$38.7K | 0.09% | 146 |
|
|
2021
Q2 | $178K | Buy |
+1,050
| New | +$178K | 0.07% | 165 |
|